company background image
600380 logo

Joincare Pharmaceutical Group IndustryLtd SHSE:600380 Stock Report

Last Price

CN¥10.58

Market Cap

CN¥20.0b

7D

-0.9%

1Y

-14.5%

Updated

16 Jul, 2024

Data

Company Financials +

Joincare Pharmaceutical Group Industry Co.,Ltd.

SHSE:600380 Stock Report

Market Cap: CN¥20.0b

600380 Stock Overview

Joincare Pharmaceutical Group Industry Co.,Ltd.

600380 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth1/6
Past Performance2/6
Financial Health5/6
Dividends5/6

Joincare Pharmaceutical Group Industry Co.,Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Joincare Pharmaceutical Group IndustryLtd
Historical stock prices
Current Share PriceCN¥10.58
52 Week HighCN¥13.25
52 Week LowCN¥9.70
Beta0.33
11 Month Change-14.88%
3 Month Change-9.50%
1 Year Change-14.47%
33 Year Change-17.86%
5 Year Change21.89%
Change since IPO-1.57%

Recent News & Updates

We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease

Jun 23
We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease

Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

May 31
Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

Recent updates

We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease

Jun 23
We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease

Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

May 31
Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings

Apr 09
Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings

Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel

Mar 04
Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel

Shareholder Returns

600380CN PharmaceuticalsCN Market
7D-0.9%1.1%2.2%
1Y-14.5%-16.2%-18.6%

Return vs Industry: 600380 exceeded the CN Pharmaceuticals industry which returned -16.2% over the past year.

Return vs Market: 600380 exceeded the CN Market which returned -18.6% over the past year.

Price Volatility

Is 600380's price volatile compared to industry and market?
600380 volatility
600380 Average Weekly Movement3.0%
Pharmaceuticals Industry Average Movement5.7%
Market Average Movement6.5%
10% most volatile stocks in CN Market9.8%
10% least volatile stocks in CN Market4.2%

Stable Share Price: 600380 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600380's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199214,365Xiong Yuwww.joincare.com

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products primarily in China. The company offers chemical preparation for drugs, including digestive tract, cardiovascular and cerebrovascular, antimicrobial, anti-tumor, assisted reproductive, neurological therapeutic, OCT, and other drugs; and traditional Chinese drug preparation production, which includes anti-tumor and cold products.

Joincare Pharmaceutical Group Industry Co.,Ltd. Fundamentals Summary

How do Joincare Pharmaceutical Group IndustryLtd's earnings and revenue compare to its market cap?
600380 fundamental statistics
Market capCN¥20.04b
Earnings (TTM)CN¥1.42b
Revenue (TTM)CN¥16.43b

14.0x

P/E Ratio

1.2x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600380 income statement (TTM)
RevenueCN¥16.43b
Cost of RevenueCN¥6.48b
Gross ProfitCN¥9.94b
Other ExpensesCN¥8.52b
EarningsCN¥1.42b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

Aug 24, 2024

Earnings per share (EPS)0.76
Gross Margin60.54%
Net Profit Margin8.64%
Debt/Equity Ratio21.7%

How did 600380 perform over the long term?

See historical performance and comparison

Dividends

1.7%

Current Dividend Yield

24%

Payout Ratio

Does 600380 pay a reliable dividends?

See 600380 dividend history and benchmarks
When do you need to buy 600380 by to receive an upcoming dividend?
Joincare Pharmaceutical Group IndustryLtd dividend dates
Ex Dividend DateJul 18 2024
Dividend Pay DateJul 18 2024
Days until Ex dividend1 day
Days until Dividend pay date1 day

Does 600380 pay a reliable dividends?

See 600380 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.